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Abstract
Background: The Chlamydia trachomatis incidence rate in Finnmark, the most northern and sparsely populated county in
Norway, has been twice the national average. This population based cross-sectional study among Finnmark high school
students had the following aims: i) to examine distribution of multilocus sequence types (STs) of C. trachomatis in a
previously unmapped area, ii) to compare chlamydia genetic diversity in Finnmark with that of two urban regions, and iii) to
compare discriminatory capacity of multilocus sequence typing (MLST) with conventional ompA sequencing in a large
number of chlamydia specimens.
Methodology: ompA sequencing and a high-resolution MLST system based on PCR amplification and DNA sequencing of
five highly variable genetic regions were used. Eighty chlamydia specimens from adolescents aged 15–20 years in Finnmark
were collected in five high schools (n=60) and from routine clinical samples in the laboratory (n=20). These were
compared to routine clinical samples from adolescents in Tromsø (n=80) and Trondheim (n=88), capitals of North and
Central Norway, respectively.
Principal Findings: ompA sequencing detected 11 genotypes in 248 specimens from all three areas. MLST displayed 50 STs
providing a five-fold higher resolution. Two-thirds of all STs were novel. The common ompA E/Bour genotype comprised
46% and resolved into 24 different STs. MLST identified the Swedish new variant of C. trachomatis not discriminated by
ompA sequencing. Simpson’s discriminatory index (D) was 0.93 for MLST, while a corrected Dc was 0.97. There were no
statistically significant differences in ST genetic diversity between geographic areas. Finnmark had an atypical genovar
distribution with G being predominant. This was mainly due to expansion of specific STs of which the novel ST161 was
unique for Finnmark.
Conclusions/Significance: MLST revealed multiple new STs and a larger genetic diversity in comparison to ompA
sequencing and proved to be a useful tool in molecular epidemiology of chlamydia infections.
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Introduction
Despite widespread efforts to control Chlamydia trachomatis,i t
remains the leading cause of bacterial sexually transmitted
infections in Scandinavia and worldwide. The prevalence is
highest among 15–24 year-olds [1]. In Norway, genital chlamydia
infections have been part of the national surveillance system for
communicable diseases since 2003. Treatment is free of charge,
and partner tracing is compulsory. As in other western countries
having implemented extensive chlamydia testing, the reported
number of chlamydia infections in Norway almost doubled since
the mid-1990s [1]. The highest incidence rates have been reported
in Finnmark, the most northern and sparsely populated county in
Norway with an incidence rate of 8.98/1000 in 2009, almost twice
the national average (4.67/1000) [2].
Strain typing of C. trachomatis is important to understand the
genetic population structure and is a useful tool in epidemiological
studies, in investigation of infection transmission or recurrence, in
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such as the Swedish new variant of C. trachomatis (nvCT) [3]. It is
assumed that persons infected by the same chlamydia strain are
more likely to be epidemiologically linked than those infected with
different strains. Traditional typing differentiated genital C.
trachomatis into subgroups based on serospecificity for the major
outer membrane protein (MOMP), encoded by the ompA gene.
MOMP and ompA based methods have predominated typing in the
past decades [4] where sequencing of the ompA gene has provided
the best discriminatory capacity [5]. As these methods identified
only a limited number of distinct subtypes, and the various
subtypes could persist for a long time within a geographic area,
research has focused on developing strain typing techniques with
higher capacity of resolution. Several alternative typing systems for
C. trachomatis have been published in recent years. Two standard
multilocus sequence typing (MLST) approaches based on
housekeeping genes have a discriminatory capacity comparable
to ompA and could be useful for slowly evolving processes in
evolutionary studies, but were not used in this study due to limited
resolution [6,7]. A significantly higher resolution has been shown
for a multilocus variable number of tandem repeats (VNTR)
analysis (MLVA) system [8,9], but in an evaluation it was found
that some VNTR markers may vary with replication of single
clones and cause difficulties in interpretation [10]. In our study, we
used the MLST system developed by Klint et al. for C. trachomatis
based on PCR amplification and DNA sequencing of five highly
variable target regions (not house keeping genes), that has
displayed a three-fold higher resolution than ompA sequencing
[11] and with a resolution similar to MLVA [12]. The target
stability of this MLST scheme has proved satisfactory through
sequencing studies of the nvCT [3,13,14] and of lymphogranulo-
ma venereum C. trachomatis strains [15]. The scheme has been
applied in several Swedish studies [11,13], and the multilocus
sequence types (STs) have been included in the Uppsala University
C. trachomatis MLST database (http://mlstdb.bmc.uu.se) enabling
us to compare STs sampled in our study to STs collected in
Sweden. We expected to find a proportion of common C.
trachomatis STs in neighbouring countries Norway and Sweden,
including the nvCT.
The aims of our study were: i) to examine distribution of C.
trachomatis STs in an adolescent population in an unmapped high-
incidence area in North Norway, ii) to compare the genetic
diversity in a remote sparsely populated county with that of two
urban regions in Norway, and iii) to compare the discriminatory
capacity of the MLST scheme developed by Klint et al. with
conventional ompA sequencing by applying both methods to a large
number of chlamydia specimens from different geographic
locations. To achieve this, we conducted a population based
cross-sectional study collecting chlamydia specimens from high
school students in Finnmark county, an extended county with
minor municipalities and a population of only 72,500 (www.ssb.
no, Statistics Norway). Additional chlamydia specimens from
adolescent girls and boys were collected from routine clinical
samples in Tromsø and Trondheim, capitals of North and Central
Norway, respectively. Our approach resulted in a total of 248 C.
trachomatis specimens that were successfully genotyped, enabling us
to assess genetic diversity within the different catchment areas, and
compare the resolution of the two methods.
Methods
Study population and urine sampling
A population based cross-sectional study was conducted among
girls and boys in five senior high schools in Finnmark county
during fall 2009 (manuscript in preparation). Briefly, the
participants filled in a web-based questionnaire on demography,
sexual behaviour and urogenital symptoms, and provided first-
void urine samples under supervision of the study staff, giving a
total of 60 chlamydia specimens from 1,476 urine samples that
were analysed at the laboratory at the University Hospital of
North Norway (UNN, Tromsø). Parallel to the high school study,
20 and 80 chlamydia positive urine samples from 15–20 year-olds
in Finnmark and the Tromsø region, respectively, were consec-
utively collected from routine clinical samples at UNN Tromsø.
Eighty-eight samples from patients of the same age group in the
Trondheim region were collected at St. Olavs Hospital (Central
Norway). After processing, a total of 248 chlamydia samples were
immediately frozen at 270uC in the laboratories and later
transported on dry ice to the University Hospital of Uppsala
(Sweden) for genotyping.
Laboratory testing of urine samples
Chlamydia PCR. The UNN laboratory extracted DNA
using the BUGS’n BEADS TM-STI kit (NorDiag ASA, Oslo,
Norway) and used the ProCt real-time PCR (ProCelo A/S,
Tromsø, Norway) with sensitivity 97% and specificity 100%. The
Trondheim laboratory prepared DNA using the bacterial protocol
on GenoM 48 (Qiagen, Hilden, Germany) and used an in-house
triplex real-time PCR (cryptic plasmid, MOMP gene and internal
control) with sensitivity 96% and specificity 100% [16]. A plasmid
specific PCR was used to confirm MLST identification of the
nvCT [17].
Strain typing. ompA sequence determination was performed
according to a previously described method [18] and strains were
categorized into genovars D–K and ompA genotypes. Genovars
denote subgroups of C. trachomatis based on serospecificity for
MOMP inferred from ompA sequencing. Genotypes are
subgroups based on ompA sequencing. The MLST scheme
comprises five highly variable target regions and was performed
as previously described [11] except that the pbpB region was
amplified as two separate fragments according to Jurstrand et al.
[13]. Allele numbers were assigned by comparing the sequence at
each locus to all known corresponding alleles available in the
Uppsala University C. trachomatis MLST database (http://mlstdb.
bmc.uu.se). Allele profiles based on the five genetic regions are
expressed as multilocus sequence types (STs). At baseline date
February 16
th 2010, the database included 145 STs originating
from 467 chlamydia isolates. In our study, clonal complexes are
defined as clusters of genetically related STs with only one allele
difference, i.e. single-locus variants (SLVs). The founder of a
clonal complex is the ST that differs from the largest number of
other STs at only a single locus, i.e. the ST that has the highest
number of SLVs.
Ethics
In the high school study, written informed consent was obtained
from the next of kin, carers or guardians on the behalf of
participants younger than 16 years. Participants 16 years or older
gave their informed consent by filling in a web-based question-
naire in accordance with the Health Research Act 117.b stating
their right to consent. All procedures were approved by the
Regional Committees for Medical and Health Research Ethics
North Norway (REK Nord No.: 200900528-6/MRO/400) and
the Data Protection Officer at UNN (No.: 2009/2475). Establish-
ment of a research bio-bank for C. trachomatis specimens was
approved by The National Directorate of Health (Bio-bank
Registry No. 2723).
Genotyping of Chlamydia trachomatis in Norway
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e34452Statistical methods
SPSS 18.0 for Windows was used for statistical analysis of the
associations between urogenital symptoms, and STs and clonal
complexes (chi-square). Binominal confidence intervals were
calculated according to Clopper-Pearsson exact method [19].
The discriminatory power (D) of a typing method refers to the
probability that two unrelated strains sampled from the test
population will be placed into different typing groups. D was
determined for ompA genotyping and MLST in the 188 routine
clinical samples using Hunter and Gaston’s modification of
Simpson’s discriminatory index [20]:
D~1{
1
NN {1 ðÞ
X S
j~1
nj(nj{1)
where N is the number of unrelated strains tested, s is the number
of different types, and nj is the number of strains belonging to the
jth type. Confidence interval (CI) for D was calculated as originally
described by Simpson [21]. A cut-off value for D of $0.95 for a
molecular typing method is considered ‘ideal’ [22]. As the 188
samples were consecutively collected in the laboratories from a
defined age group and within a limited time frame from defined
geographic areas, a degree of epidemiological relatedness could
not be excluded. The following assumptions were made: the two
most common STs in an ‘ideal’ epidemiologically independent
sample will have prevalences equal to the third most prevalent ST.
Thus, nST12 and nST56 were set equal to ST153 (n=15), and a
corrected Dc was calculated. BioNumerics software (version 6.01,
Applied Maths, Sint-Martens-Latem, Belgium) was used to
generate a minimum spanning tree under the categorical
coefficient of similarity and the priority rule of the highest number
of single-locus variants.
Results
A complete MLST profile was obtained for all 248 chlamydia
specimens identifying a total of 50 STs (Table 1). ompA sequencing
detected 11 genotypes, thus the MLST scheme provided 4.5
higher resolution than ompA. By combining MLST and ompA,5 3
unique genotypes were identified. The commonly predominating
ompA E/Bour genotype comprised 46% of all specimens and could
be further resolved by the MLST system into 24 different STs, i.e.
giving 24 times higher resolution. Nineteen percent of all
specimens belonged to genovar G which could be further resolved
into nine different STs.
Simpson’s discriminatory index (D) was calculated in the 188
routine clinical samples (Table S1) and was 0.93 (95% CI 0.91–
0.95) for MLST and 0.67 (95% CI 0.61–0.73) for ompA
sequencing, respectively. A corrected Dc of 0.97 (95% CI 0.96–
0.98) was calculated for MLST.
Among the 50 STs, 31 STs (62%) were novel, while 19 STs had
been identified previously. Novel STs were numbered in order of
identification: ST146–ST176 (Table S2). Four of the 50 STs were
singletons, i.e. differing at more than two alleles from all other
isolates. Fifty-two percent of the STs comprised only one specimen
and 62% had less than four specimens.
A total of 12 new alleles in the MLST scheme were detected
comprising 9% of all specimens (Table S2). The three most
variable regions, pbpB, hctB and CT058 displayed five, three and
three new alleles, respectively. The less variable regions CT144
had one new allele and CT172 had none. Most of the new alleles
were substitutions of a single base pair.
All 248 chlamydia specimens were clustered using a minimum
spanning tree based on the STs (Figure 1). ST12, ST30, ST56,
and ST95 were considered putative founders of a clonal complex.
All four were present in the MLST database prior to our study.
ST12 (20%) and ST56 (13%) were also the most frequent clones
and were present at all three collection sites. Of all specimens, 57%
(142 of 248) belonged to STs present in all three areas, and
included eight STs, of which ST153 and ST154 were new. Sixty-
four percent (32 of 50) of the STs were unique for specific areas.
Differences in genetic diversity as estimated by ST variation and
proportion of novel STs were not statistically significant between
the three geographic areas (Table 2).
Four of the 248 specimens were identified as ST55 which
appears to be unique to the new Swedish variant of C. trachomatis
(nvCT) [17]. One nvCT specimen was found in Finnmark and
Tromsø, respectively, as were two in Trondheim.
Genovar E was most prevalent in both Tromsø (65%, 95% CI
54–75%) and Trondheim (48%, 95% CI 37–59%) and signifi-
cantly more frequent than in Finnmark (26%, 95% CI 17–36%).
Finnmark had the most atypical genovar distribution with G being
predominant, contributing 36% (95% CI 26–47%), which was
Table 1. Number of genetic variants of ompA sequencing and multilocus sequence typing (MLST) within each genovar (D–K) in
248 C. trachomatis specimens.
Chlamydia genovars Number of genetic variants
Genovar No of specimens (%) ompA genotypes STs
1 STs with ompA
D 21 (8.5) 2 3 3
E 115 (46.4) 2 24 25
F 44 (17.7) 1 6 6
G 47 (19.0) 2 9 9
H 5 (2.0) 1 2 2
I 1 (0.4) 1 1 1
J 1 (0.4) 1 1 1
K 14 (5.6) 1 6 6
Total 248 (100.0) 11 50
2 53
2
1Sequence types (STs) of C. trachomatis detected by MLST.
2The numbers reflect the total number of unique genetic variants in the 248 chlamydia specimens and do not equal the sum of each column.
doi:10.1371/journal.pone.0034452.t001
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Trondheim (9%, 95% CI 4–17%). The predominance of genovar
G in Finnmark was mainly due to the expansion of ST128 and the
novel ST161 (Figure 1).
In Finnmark, ST12 (25%), ST161 (19%) and ST128 (13%) were
the most prevalent chlamydia clones (Figure 1). The novel ST161
was almost unique for Finnmark. It was identified in four of the
five high schools and was equally distributed between the genders.
In subjects infected with ST161, there were as many symptomatic
as asymptomatic individuals. ST128 was not prevalent in Tromsø
(3%) or Trondheim (1%).
Among the 20 STs identified in the Finnmark high school study,
six STs were found in both genders, twelve STs were present in
girls only, and two STs were present only in boys. The founders
ST12 and ST56, and the novel ST161, were among the six STs
shared between genders. Among the two STs found in boys only,
one specimen of ST33 was identified in a male participant in
Finnmark who reported having sex with men. Chlamydia infected
girls had a higher proportion of samples with gender-specific STs
(34%, 95% CI 20–51%) compared to infected boys (11%, 95% CI
1.3–33%).
Among participants in the high school study, 59% of chlamydia
infected girls and 22% of infected boys (p=0.01) reported
urogenital symptoms. No statistically significant associations
between clinical symptoms and specific STs or clonal complexes
were found.
Discussion
This is the largest study to date using this MLST system and is
also the study where MLST has outperformed ompA the most by
offering a five-fold higher resolution than ompA genotyping,
compared with the three-fold increase described earlier [11]. We
observed a discriminatory index D of 0.93 (95% CI 0.91–0.95)
which was slightly lower than expected in such a large number of
samples. A cut-off value$0.95 is considered ‘ideal’ for molecular
Figure 1. Minimum spanning tree analysis based on 50 multilocus sequence types (STs) in 248 chlamydia specimens. The 50 circles
correspond to different STs discriminated by multilocus sequence typing (MLST). Each circle represents an ST, and ST number is given inside or next
to the circle. Circle size reflects the number of isolates. Bold black lines connect single-locus variants (SLV). Broken lines connecting double-locus
variants are only indicative as several alternative links with equal weight may exist. The coloured pie charts indicate ST geographic distribution. Grey
shaded areas define clonal complexes i.e. clusters of genetically related STs with only one allele difference.
doi:10.1371/journal.pone.0034452.g001
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could indicate that the 188 laboratory samples were not
completely epidemiologically independent, and we therefore
decided to use a prevalence correction for the two most frequent
STs. We calculated a significantly higher corrected Dc of 0.97
(95% CI 0.96–0.98) with the entire confidence interval above the
cut-off value. Two previous studies fulfilling the above sampling
criteria, but with only a small number of samples (both n=31)
reported D between 0.95 and 0.96 for this MLST scheme [10,12].
Confidence intervals were not assessed in these studies. As D
includes no correcting factor for small populations, typing schemes
should not be validated with small samples [20].
The MLST scheme resolved the chlamydia specimens into a
number of STs of which a significant proportion comprised only a
few specimens and two-thirds were novel. The minimum spanning
tree analysis (Figure 1) showed that the majority of specimens
belonged to clonal complexes which have also been observed in
other bacterial MLST databases [23]. Organization into clonal
complexes makes MLST data more suitable to epidemiologic
analysis and reduces the potential of over-discrimination. The
multiple novel STs could be due to the relatively short existence of
the database only since 2007. In addition, genotyping of
chlamydia strains from individuals in an unmapped geographic
area will commonly identify a number of novel STs. As the
database expands with time, it is expected that genetic
relationships between more STs will be revealed. Prior to this
study, Norwegian chlamydia specimens from heterosexuals had
not been characterized using this MLST scheme.
Among the founders of clonal complexes, ST12 was the most
prevalent constituting one-fifth of the strains in all three areas.
ST12 is common among both heterosexuals and men having sex
with men (MSM) in Sweden and other European countries. ST30
and ST56 are also frequently reported to the database. The
founder ST95 (one female, Finnmark) had previously been
identified in only three samples from Dutch females illustrating
how an individual through sexual contact might have intercon-
nected geographically distant areas.
A nvCT prevalence of 1.6% was as expected as nvCT has rarely
been identified outside Sweden [24]. These infections could have
been imported directly from Sweden, but may also reflect
domestic spread. As the questionnaire did not include ethnicity
or origin country of former sex partners, we could not examine
any links to Sweden. A previous study found that the nvCT
prevalence in Oslo increased from 1.0% in the first quarter of
2007 to 3.4% in the second quarter of 2008, indicating a slow
spread within Norway [25]. The laboratories in Tromsø and
Trondheim have used nvCT sensitive diagnostic assays since 2005
and 2006, respectively, implying that the nvCT clone has not
escaped detection in these areas.
One specimen from Finnmark contained an ST33 genotype
which had previously only been found among MSM in Stockholm
(Sweden) and France. ST33 was detected in a Finnmark male who
reported having sex with men which could indicate links to
international MSM networks. Due to limited epidemiological data
on previous sex partners we could not confirm this hypothesis. The
discrimination of nvCT and ST33 is not possible using ompA
sequencing.
Genovar E was the most common genovar in Tromsø and
Trondheim, as in heterosexual populations elsewhere [5,26]. The
predominance of genovar G in Finnmark is unusual in
heterosexual populations and was mainly due to the expansion
of ST128 and ST161. As the 20 routine clinical samples also were
restricted to the 15–20 year-olds, we could not determine whether
the genovar distribution in our study reflects the distribution in the
general population in Finnmark. The uniquely high occurrence of
ST128 and ST161 in Finnmark and no significant spread to
neighbouring Tromsø may be explained by these clones being
limited to local sexual networks in Finnmark. However, we could
not confirm this hypothesis due to lack of sexual network
information.
Possible factors contributing to the success of ST12, ST128 and
ST161 in Finnmark could be a high transmission rate reflecting
increased tissue tropism, or the strains causing a silent infection
escaping discovery. However, all three strains were symptomatic in
approximately half of infected participants in the high school
study. Due to only 60 chlamydia specimens carrying behavioural
data, the reasons for the success of ST12, ST128 and ST161
cannot be further elucidated. As previously shown, no associations
between urogenital symptoms and specific STs or clonal
complexes were found [27].
Table 2. Geographic distribution of C. trachomatis specimens according to three different strain typing methods, and genetic
diversity within each area.
Geographic area Finnmark
1 Tromsø Trondheim Total
2
No of chlamydia specimens 80 80 88 248
No of STs
3 21 27 28 50
No of novel STs 10 18 14 31
No of cases with novel STs 33 34 34 101
ST variation
4 (95% CI) 0.26 (0.17–0.40) 0.34 (0.23–0.44) 0.32 (0.22–0.41) 0.20 (0.15–0.25)
% novel STs
5 (95% CI) 47.6 (26.3–69.0) 66.7 (48.9–84.5) 50.0 (31.5–68.5) 62.0 (48.6–75.5)
No of genovars
6 D – K 6778
No of ompA genotypes
7 71 0 91 1
CI: Confidence interval.
1C. trachomatis specimens from either the high school study (n=60) or routine clinical samples in the laboratory (n=20).
2The numbers reflect the results for all 248 specimens and do not necessarily equal the sum of each row.
3Sequence types of C. trachomatis detected by multilocus sequence typing.
4Number of STs identified in an area divided by number of chlamydia specimens in the area.
5Percentage novel STs in an area of total number of STs in the area.
6Genovar D–K of C. trachomatis inferred from ompA sequencing.
7Genotypes of C. trachomatis detected by ompA sequencing.
doi:10.1371/journal.pone.0034452.t002
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higher proportion of gender-specific STs compared to boys. This
may indicate that a significant proportion of female students had
off-school sex partners, and therefore were infected with STs not
identified in their high school male peers. This was supported by
the girls reporting older partners at last intercourse (19.9 years)
compared to the boys (16.3 years, p,0.01). The propensity of
young girls to have older partners has also been shown in other
studies [28].
The achievement of a complete MLST profile for all 248
samples was unexpected compared to previous studies. However,
all specimens were new and fresh, they were frozen at 270uC
immediately after the first diagnostic PCR, and they were thawed
for the first time prior to MLST to avoid degradation of DNA. In
addition, the MLST method has been optimized since the
introduction in 2007 which also could have contributed to the
high success rate [13]. Thus, we consider the results reliable.
Presently our MLST system is too labour intensive to enable
epidemiological analysis in clinical routine with partner notifica-
tion. Future research should focus on development of a typing
scheme with a high discriminatory power that allows for rapid and
easy interpretation, but which also is economically affordable.
Next generation sequencing technologies may in the future reach
this objective. In an area where the chlamydia STs are known,
array-based methods for analysis of sequence variation might be
an alternative, but this approach will not detect STs with novel
alleles [29].
In conclusion, our study shows that this MLST scheme is a
valuable tool for studying the molecular epidemiology of C.
trachomatis infections and far superior to ompA typing in terms of
resolution especially of the globally predominant genovar E.
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